SCHEMBL21976378

SCHEMBL21976378

c1ccc(-c2ccc(N(c3ccccc3)c3ccc(-c4ccc(N(c5ccccc5)c5ccc6oc7ccccc7c6c5)cc4)c(-c4ccccc4)c3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PLA2G2A P14555 5/20 0.38
▸ PLA2G4A P47712 5/20 0.38
▸ AHR P35869 2/20 0.36
▸ TNKS O95271 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21975863 0.99 HPGD (0.41) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL24306683 0.95 PLA2G2A (0.41) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25629037 0.92 PLA2G2A (0.42) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL21975905 0.92 AHR (0.40) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL20441978 0.92 HPGD (0.41) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL24370038 0.92 HPGD (0.44) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25098398 0.92 HPGD (0.44) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL23172154 0.92 MAPT (0.46) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL14295459 0.92 MAPT (0.46) NPC1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL14295463 0.92 MAPT (0.46) NPC1HPGDMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11825740-B2 Amine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 — — US disclosed
US-11825740-B2 Amine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 — — US disclosed
US-20200144507-A1 AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144507-A1 AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, AOC1, AOC3 NPC1 3176/4885HPGD 3777/4885MAPT 446/4885
US-11825740-B2 Amine compound and organic light-emitting device including the same AOC2, AOC1, AOC3 NPC1 3176/4885HPGD 3777/4885MAPT 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback